Trial · NCT07891845
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of Participants With Seroma at Postoperative Day 30 | Postoperative Day 30 | Percentage of participants with a seroma in the operated inguinal or scrotal region at postoperative day 30. Seroma is defined as a fluctuant fluid collection detected on physical examination and/or a fluid collection demonstrated by ultrasonography. Ultrasonography will be performed when examination findings are uncertain or a seroma is clinically suspected. Seroma rates will be compared between groups to assess non-inferiority of PAS using an absolute margin of 15 percentage points. |
| Other | Operative Time | Intraoperative period, from skin incision to skin closure | Duration of surgery in minutes, measured from the first skin incision to final skin closure. |
| Other | Postoperative Pain Score | Postoperative Days 1 and 7, and Months 1, 6, and 12 | Pain intensity measured on a 0-10 visual analog scale or numeric rating scale, where 0 indicates no pain and 10 indicates the worst imaginable pain. |
| Other | Hernia-Related Quality of Life | Baseline and Postoperative Months 1, 6, and 12 | Hernia-related quality of life assessed using the EuraHS-QoL questionnaire, covering pain, activity restriction, and cosmetic discomfort. Higher scores indicate worse quality of life. Postoperative scores will be compared between groups and with baseline values. |
| Other | Length of Hospital Stay | From surgery to hospital discharge, an average of 1 day | Duration of hospitalization in days following hernia repair, measured from surgery to discharge. |
| Other | Time to Return to Normal Daily Activities | From surgery through postoperative Month 12 | Number of days from surgery until the participant can independently perform basic daily activities without a marked increase in analgesic requirements. |
| Other | Postoperative Complications | Through postoperative Month 12 | Percentage of participants experiencing postoperative complications. Complications will be graded according to the Clavien-Dindo classification. |
| Other | Postoperative Hematoma | Through postoperative Month 12 | Percentage of participants with a hematoma in the operated inguinal or scrotal region. |
| Other | Postoperative Hydrocele | Through postoperative Month 12 | Percentage of participants with a postoperative hydrocele on the operated side. |
| Other | Postoperative Scrotal Edema | Through postoperative Month 12 | Percentage of participants with postoperative scrotal edema. |
| Other | Surgical Site Infection | Through postoperative Month 12 | Percentage of participants with a surgical site infection following hernia repair. |
| Other | Postoperative Testicular Pain | Postoperative Days 1 and 7, and Months 1, 6, and 12 | Percentage of participants reporting testicular pain on the operated side. |
| Other | Postoperative Urinary Retention | Through postoperative Month 12 | Percentage of participants experiencing urinary retention following surgery. |
| Other | Chronic Inguinal Pain | Postoperative Months 6 and 12 | Percentage of participants reporting persistent pain in the operated inguinal region at the 6-month and 12-month follow-up assessments. |
| Other | Hernia Recurrence | Through postoperative Month 12 | Percentage of participants with a recurrent hernia on the operated side, confirmed by clinical examination and/or ultrasonography. |
| Other | Intraoperative Complications | Intraoperative period, from skin incision to skin closure | Percentage of participants experiencing intraoperative complications, including injury to the spermatic cord, vas deferens, testicular vessels, inferior epigastric vessels, bladder, or bowel, and peritoneal tears. |
| Other | Conversion to Open Surgery | Intraoperative period, from skin incision to skin closure | Percentage of participants whose planned laparoscopic repair is converted to open surgery. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07891845/registered